Cellex Inc.
Cellex develops, manufactures and markets diagnostic tests suitable for point-of-care use. These tests use a platform technology called Homogeneous Biochemiluminescence Assay (HBA), which enables assays that are highly sensitive and easy-to-use.
Company Location
301 Cascade Pointe Lane
Cary
NC
27513
Phone
County
Region
Company Details
Company type
Year founded
2002
Employment range in NC
US headquarters
Maryland
Global headquarters
United States
Primary site activity
Products on market
QFlu NI Assay; QFlu Combo Test; QBV Test (all are currently for research use only).
Products under development
Current tests in development include the a flu test that can simultaneously diagnose influenza and antiviral drug resistance (qFLU Combo Test), a bacterial vaginosis test (qBV Test), and an antibiotic resistance test (qCPO Test).